Urethane

Urethane

SCHEMBL50516

CC(=O)O.CCOC(N)=O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Urethane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.83
ALDH1A1 P00352 6/20 0.52
LMNA P02545 4/20 0.52
HSD17B10 Q99714 2/20 0.52
GAA P10253 2/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
CHRM5 P08912 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
TSHR P16473 2/20 0.41
HTR1A P08908 1/20 0.41
CHRNB2 P17787 1/20 0.41
CYP2C19 P33261 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urethane SCHEMBL11239486 1.00 ALOX15 (0.83) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL7943960 1.00 ALOX15 (0.83) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL27766653 0.94
Urethane SCHEMBL154279 0.92 ALOX15 (0.88) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL40457 0.92 ALOX15 (0.88) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL4556053 0.92 ALOX15 (0.88) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL5371742 0.92 ALOX15 (0.88) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL8830978 0.91 ALOX15 (1.00) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL367439 0.91 ALOX15 (1.00) ALOX15ALDH1A1LMNAHSD17B10GAA
Urethane SCHEMBL8505249 0.91 ALOX15 (1.00) ALOX15ALDH1A1LMNAHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 999 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118175990-A Osmotic formulation composition comprising an acid sensitive ingredient 奥德森生物有限公司 2024-06-11 CN claimed
CN-116284932-A Slow-expansion type high-expansion-ratio water-swelling rubber water stop strip and preparation method thereof 中裕铁信交通科技股份有限公司 2023-06-23 CN claimed
WO-2023090720-A1 OSMOTIC AGENT COMPOSITION COMPRISING ACID-SENSITIVE INGREDIENT 오즈온바이오 주식회사 2023-05-25 WO claimed
WO-2023090719-A1 OSMOTIC AGENT COMPOSITION COMPRISING ACID-SENSITIVE INGREDIENT 오즈온바이오 주식회사 2023-05-25 WO claimed
US-20220000788-A1 METHOD FOR DRY POWDER COATING CAPSULES NINGBO WESTON POWDER PHARMA COATINGS CO., LTD. (CN) 2022-01-06 US claimed
EP-3813801-A2 EXTENDED RELEASE OSMOTIC TABLET DOSAGE FORM COMPRISING METFORMIN AND SITAGLIPTIN Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) 2021-05-05 EP claimed
US-20200222330-A1 METHOD FOR DRY POWDER COATING CAPSULES POWDER PHARMA COATING INC. (CA) 2020-07-16 US claimed
CN-111317207-A Anti-aging elastic swimsuit fabric and preparation method thereof 晋江市七彩狐服装织造有限公司 2020-06-23 CN claimed
US-20190099378-A1 METHOD FOR DRY POWDER COATING CAPSULES NINGBO WESTON POWDER PHARMA COATINGS CO., LTD. (CN) 2019-04-04 US claimed
US-20190099377-A1 METHOD FOR DRY POWDER COATING OSMOTIC DRUG DELIVERY SYSTEM NINGBO WESTON POWDER PHARMA COATINGS CO., LTD. (CN) 2019-04-04 US claimed
US-6706283-B1 INCREASING BIOAVAILABILITY OF SPARINGLY WATER SOLUBLE ACTIVE INGREDIENTS; CONTROLLED INFLUX OF WATER TO CORE USING NON-DISSOLVING, NONERODING COATING PFIZER INC 2004-03-16 US claimed
WO-2003092660-A1 MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM RANBAXY LABORATORIES LIMITED (US) 2003-11-13 WO claimed
CN-1089821-C Elastic polyurethane fiber and process for producing same ASAHI CHEMICAL IND (JP) 2002-08-28 CN claimed
US-6365185-B1 ORAL TABLET FOR DELIVERING BENEFICIAL AGENT TO MAMMAL COMPRISING CORE COMPARTMENT HAVING BENEFICIAL AGENT SURROUNDED BY UNITARY SELF-DESTRUCTING SHELL COMPRISING PLURALITY OF DISINTEGRANT PARTICLES DISPERSED WITHIN SEMIPERMEABLE MATRIX UNIVERSITY OF CINCINNATI 2002-04-02 US claimed
EP-1027888-A2 Osmotic system for delivery of solid amorphous dispersions of drugs Pfizer Products Inc. (US) 2000-08-16 EP claimed
CN-1247579-A Elastic polyurethane fiber and process for producing same ASAHI CHEMICAL IND (JP) 2000-03-15 CN claimed
CN-1147863-A Mechanism for opening and closing a resealable cartridge MINNESOTA MINING & MFG (US) 1997-04-16 CN claimed
US-5612059-A CELLULOSE DERIVATIVE, DRUG DELIVERY PFIZER INC. (US) 1997-03-18 US claimed
EP-0326727-A1 Sustained release implant and method for preparing same INTERNATIONAL MINERALS AND CHEMICAL CORPORATION (US) 1989-08-09 EP claimed
US-4761289-A Sustained release implant and method for preparing same INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1988-08-02 US claimed